Bank of America’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-37,513
| Closed | -$69.4K | – | 7101 |
|
|
2023
Q1 | $69.4K | Sell |
37,513
-3,239,186
| -99% | -$5.99M | ﹤0.01% | 5590 |
|
|
2022
Q4 | $3.64M | Buy |
3,276,699
+3,265,185
| +28,358% | +$3.62M | ﹤0.01% | 3178 |
|
|
2022
Q3 | $27K | Buy |
11,514
+2,718
| +31% | +$6.37K | ﹤0.01% | 6074 |
|
|
2022
Q2 | $27K | Sell |
8,796
-39,303
| -82% | -$121K | ﹤0.01% | 6280 |
|
|
2022
Q1 | $327K | Sell |
48,099
-13,193
| -22% | -$89.7K | ﹤0.01% | 5390 |
|
|
2021
Q4 | $512K | Buy |
61,292
+51,989
| +559% | +$434K | ﹤0.01% | 5077 |
|
|
2021
Q3 | $69K | Sell |
9,303
-3,919
| -30% | -$29.1K | ﹤0.01% | 6020 |
|
|
2021
Q2 | $90K | Sell |
13,222
-16,939
| -56% | -$115K | ﹤0.01% | 5774 |
|
|
2021
Q1 | $310K | Buy |
30,161
+24,146
| +401% | +$248K | ﹤0.01% | 5087 |
|
|
2020
Q4 | $42K | Sell |
6,015
-2,569
| -30% | -$17.9K | ﹤0.01% | 5625 |
|
|
2020
Q3 | $70K | Sell |
8,584
-2,170
| -20% | -$17.7K | ﹤0.01% | 5227 |
|
|
2020
Q2 | $74K | Sell |
10,754
-1,052
| -9% | -$7.24K | ﹤0.01% | 5241 |
|
|
2020
Q1 | $56K | Buy |
11,806
+4,073
| +53% | +$19.3K | ﹤0.01% | 5233 |
|
|
2019
Q4 | $68K | Sell |
7,733
-26,396
| -77% | -$232K | ﹤0.01% | 5337 |
|
|
2019
Q3 | $113K | Sell |
34,129
-5,113
| -13% | -$16.9K | ﹤0.01% | 5176 |
|
|
2019
Q2 | $194K | Buy |
39,242
+8,134
| +26% | +$40.2K | ﹤0.01% | 4910 |
|
|
2019
Q1 | $193K | Sell |
31,108
-3,974
| -11% | -$24.7K | ﹤0.01% | 4818 |
|
|
2018
Q4 | $118K | Buy |
35,082
+9,544
| +37% | +$32.1K | ﹤0.01% | 5086 |
|
|
2018
Q3 | $166K | Sell |
25,538
-3,069
| -11% | -$19.9K | ﹤0.01% | 4887 |
|
|
2018
Q2 | $219K | Buy |
28,607
+20,276
| +243% | +$155K | ﹤0.01% | 4664 |
|
|
2018
Q1 | $187K | Buy |
8,331
+573
| +7% | +$12.9K | ﹤0.01% | 4708 |
|
|
2017
Q4 | $99K | Buy |
7,758
+4,358
| +128% | +$55.6K | ﹤0.01% | 4962 |
|
|
2017
Q3 | $53K | Buy |
3,400
+1,208
| +55% | +$18.8K | ﹤0.01% | 5127 |
|
|
2017
Q2 | $30K | Buy |
2,192
+1,030
| +89% | +$14.1K | ﹤0.01% | 5328 |
|
|
2017
Q1 | $26K | Buy |
+1,162
| New | +$26K | ﹤0.01% | 5462 |
|